Further studies on the regulation, localization and function of the TRH-like peptide pyroglutamyl-glutamyl-prolineamide in the rat anterior pituitary gland
| Autor: | W. Klootwijk, G A C van Haasteren, W. J. De Greef, E Linkels, J. M. M. Rondeel, S M Cockle, Theo J. Visser, Piet Kramer, F. H. De Jong, M E Everts, Leo J. Hofland, W P H M Jeucken |
|---|---|
| Rok vydání: | 1995 |
| Předmět: |
Male
endocrine system Pituitary gland medicine.medical_specialty Endocrinology Diabetes and Metabolism Radioimmunoassay Thyrotropin-releasing hormone Gonadotropin-releasing hormone Biology Gonadotropin-Releasing Hormone Endocrinology Estrus Anterior pituitary Pituitary Gland Anterior Internal medicine medicine Animals Rats Wistar Thyrotropin-Releasing Hormone Cells Cultured Estrous cycle Antagonist Pyrrolidonecarboxylic Acid Rats medicine.anatomical_structure Animals Newborn Female Hormone |
| Zdroj: | Journal of Endocrinology. 146:293-300 |
| ISSN: | 1479-6805 0022-0795 |
| DOI: | 10.1677/joe.0.1460293 |
| Popis: | Recent evidence shows that thyrotrophin-releasing hormone (TRH) immunoreactivity in the rat anterior pituitary gland is accounted for by the TRH-like tripeptide prolineamide-glutamyl-prolineamide (pGlu-Glu-ProNH2, 2). The present study was undertaken to investigate further the regulation, localization and possible intrapituitary function of 2. Anterior pituitary levels of 2 were determined between days 5 and 35 of life, during the oestrous cycle and after treatment with the luteinizing hormone-releasing hormone (LHRH) antagonist Org 30276. Treatment of adult males with the LHRH antagonist either for 1 day (500 μg/100 g body weight) or for 5 days (50 μg/100 g body weight) reduced anterior pituitary 2 levels by 25–30% (P2 increased between days 5 and 35 of life. In females, these levels were 2- to 3-fold higher (P2 levels in female rats decreased in parallel with a decrease in plasma FSH. Injections with the LHRH antagonist (500 μg/100 g body weight), starting on day 22 of life, led to reduced contents of 2 in the anterior pituitary gland of female rats on days 26 and 30 (55 and 35% decrease respectively). Levels of 2 in the anterior pituitary gland did not change significantly during the oestrous cycle. Fractionation of anterior pituitary cells by unit gravity sedimentation was found to be compatible with the localization of 2 in gonadotrophs. In vitro, 2 dose-dependently inhibited TRH-stimulated growth hormone (GH) release from anterior pituitary cells obtained from neonatal rats, but no consistent effects were seen on the in vitro release of luteinizing hormone (LH), FSH, prolactin (PRL) or thyroid-stimulating hormone (TSH) under basal or TRH/LHRH-stimulated conditions. Furthermore, 2 did not affect the in vitro hormone release by anterior pituitary cells obtained from adult rats. In vivo, 2 (0·3–1·0 μg intravenously) did not affect plasma PRL, TSH, LH, FSH and GH in adult male rats. We conclude that 2 in the anterior pituitary gland is regulated by LHRH, is probably localized in gonadotrophs and may play a (paracrine) role in neonatal GH release. Journal of Endocrinology (1995) 146, 293–300 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|